{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:10:45Z","timestamp":1794643845572,"version":"4.9.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>\n                    Mesonephric adenocarcinoma most commonly arises in the cervix and is presumed to be derived from normal or hyperplastic mesonephric remnants. It is characterized by recurrent\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    mutations and lack of\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    alterations. Adenocarcinomas of the uterine corpus and ovary characterized by morphologic and immunophenotypic similarities to mesonephric adenocarcinoma have been reported. The pathogenesis of these tumors, which have been designated \u201cmesonephric-like adenocarcinomas\u201d is unknown, and it has been debated whether these represent mesonephric adenocarcinomas that arise in the endometrium\/ovary or endometrioid adenocarcinomas that closely mimic mesonephric adenocarcinoma. The relationship at the molecular level between mesonephric adenocarcinomas and mesonephric-like adenocarcinomas is unknown. The aim of this study was to examine the molecular alterations in mesonephric-like adenocarcinomas to identify driver mutations and potential therapeutically targetable mutations, and to determine the relationship between mesonephric-like adenocarcinomas and mesonephric adenocarcinomas using targeted next-generation sequencing. Seven mesonephric-like adenocarcinomas (4 ovarian, 3 uterine corpus) underwent targeted next-generation sequencing to detect mutations, copy number variations and structural variants in exonic regions of 300 cancer genes, and 113 selected intronic regions across 35 genes. All 7 tumors (100%) harbored canonical activating\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    mutations (4 G12D, 3 G12V).\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    activating mutations were identified in 3 of 7 (43%) cases. There were no alterations in\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ARID1A<\/jats:italic>\n                    , or\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    in any of the tumors. In copy number analysis, 5 of 7 (71%) tumors exhibited 1q gain, which was accompanied by 1p loss in 2 cases. In addition, 4 of 7 (57%) tumors had chromosome 10 gain, which was accompanied by gain of chromosome 12 in 3 cases. Mesonephric-like adenocarcinomas, similar to mesonephric adenocarcinomas, are characterized by recurrent\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    mutations, gain of 1q, lack of\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    mutations, and gains of chromosomes 10 and 12.\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    mutations, which have not previously been identified in mesonephric adenocarcinoma, were found in 3 of 7 (43%) mesonephric-like adenocarcinomas in our study. Mesonephric-like adenocarcinomas exhibit strikingly similar molecular aberrations to mesonephric adenocarcinomas, but also frequently harbor\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    mutations, demonstrating biological overlap with carcinomas of both mesonephric and Mullerian (endometrioid) differentiation. Given the previously documented association with endometriosis (ovarian neoplasms) and the prominent endometrial involvement (uterine corpus neoplasms), we believe these are best regarded as of Mullerian origin and representing adenocarcinomas which differentiate along mesonephric lines; as such, we propose the term mesonephric-like Mullerian adenocarcinoma.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000000958","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T19:26:11Z","timestamp":1507058771000},"page":"227-233","source":"Crossref","is-referenced-by-count":159,"title":["Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract"],"prefix":"10.1097","volume":"42","author":[{"given":"Jelena","family":"Mirkovic","sequence":"first","affiliation":[{"name":"Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"McFarland","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette M.","family":"Sholl","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Lindeman","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"MacConaill","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Women\u2019s and Perinatal Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Women\u2019s and Perinatal Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Quick","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Women\u2019s and Perinatal Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Women\u2019s and Perinatal Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240215","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R2-20240215","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R3-20240215","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R4-20240215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R5-20240215","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gku1211","article-title":"BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers","volume":"43","author":"Abo","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R6-20240215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-11-0184","article-title":"High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing","volume":"2","author":"Wagle","year":"2012","journal-title":"Cancer Discov"},{"key":"R7-20240215","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R8-20240215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"R9-20240215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R10-20240215","doi-asserted-by":"crossref","first-page":"E2423","DOI":"10.1002\/humu.22771","article-title":"Oncotator: cancer variant annotation tool","volume":"36","author":"Ramos","year":"2015","journal-title":"Hum Mutat"},{"key":"R11-20240215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R12-20240215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R13-20240215","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R14-20240215","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/00313027909059053","article-title":"Adenocarcinoma of the uterine cervix of probable Wolffian origin","volume":"11","author":"Buntine","year":"1979","journal-title":"Pathology"},{"key":"R15-20240215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PGP.0b013e318166067f","article-title":"Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature","volume":"27","author":"Wani","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20240215","first-page":"7012","article-title":"Mesonephric adenocarcinoma of the uterine corpus","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R17-20240215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases","volume":"28","author":"Bague","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R18-20240215","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R19-20240215","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3","volume":"33","author":"Roma","year":"2014","journal-title":"Int J Gynecol Path"},{"key":"R20-20240215","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0046-8177(99)90148-X","article-title":"Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin","volume":"30","author":"Devouassoux-Shisheboran","year":"1999","journal-title":"Hum Pathol"},{"key":"R21-20240215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000478-198303000-00002","article-title":"Ovarian tumors of probable wolffian origin. A report of 11 cases","volume":"7","author":"Young","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"R22-20240215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1066896908329585","article-title":"Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis","volume":"18","author":"Kalyanasundaram","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"R23-20240215","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/00000478-200308000-00005","article-title":"Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion","volume":"27","author":"Tambouret","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R24-20240215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00004347-199204000-00006","article-title":"Endometrioid carcinoma of the fallopian tube resembling an adnexal tumor of probable wolffian origin: a report of six cases","volume":"11","author":"Daya","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20240215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.pap.0000138141.88763.6a","article-title":"Endometrioid carcinoma of the fallopian tube resembling a female adnexal tumor of probable wolffian origin","volume":"11","author":"Fukunaga","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"R26-20240215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.prp.2009.04.010","article-title":"Endometrioid carcinoma of the fallopian tube resembling an adnexal tumor of probable wolffian origin: a case of report and review of the literature","volume":"206","author":"Huang","year":"2010","journal-title":"Pathol Res Pract"},{"key":"R27-20240215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R28-20240215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/PAS.0b013e3181c89c98","article-title":"PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma","volume":"34","author":"Rabban","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R29-20240215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PGP.0b013e3182a54afa","article-title":"PAX8 expression in uterine adenocarcinomas and mesonephric proliferations","volume":"33","author":"Yemelyanova","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R30-20240215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R31-20240215","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R32-20240215","doi-asserted-by":"crossref","DOI":"10.1097\/PGP.0000000000000368","article-title":"Female adnexal tumors of probable Wolffian origin (FATWO): a case series with next-generation sequencing mutation analysis","author":"Cossu","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R33-20240215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PGP.0000000000000222","article-title":"Value of PAX-8 and SF-1 immunohistochemistry in the distinction between female adnexal tumor of probable Wolffian origin and its mimics","volume":"35","author":"Goyal","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20240215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1066896915611489","article-title":"Mesonephric adenocarcinoma of the uterine corpus: a case report and diagnostic pitfall","volume":"24","author":"Kim","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"R35-20240215","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/00000478-200112000-00011","article-title":"Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation","volume":"25","author":"Ordi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R36-20240215","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"R37-20240215","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1038\/ctg.2016.18","article-title":"KRAS G12D mutation subtype is a prognostic factor for advanced pancreatic adenocarcinoma","volume":"7","author":"Bournet","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"R38-20240215","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group","volume":"27","author":"Modest","year":"2016","journal-title":"Ann Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201802000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T02:02:14Z","timestamp":1707962534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201802000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000958","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}